Adlai Nortye (NASDAQ:ANL) Posts Earnings Results

Adlai Nortye (NASDAQ:ANL) posted its quarterly earnings results on Friday. The company reported ($0.46) EPS for the quarter, FiscalAI reports. The company had revenue of $2.50 million during the quarter.

Adlai Nortye Price Performance

Shares of ANL stock traded down $0.84 during midday trading on Friday, reaching $11.16. 377,442 shares of the company traded hands, compared to its average volume of 580,195. The firm’s 50 day simple moving average is $8.84 and its two-hundred day simple moving average is $4.16. Adlai Nortye has a 1-year low of $0.88 and a 1-year high of $12.15.

Analysts Set New Price Targets

Several research analysts have recently commented on ANL shares. HC Wainwright upgraded Adlai Nortye from a “neutral” rating to a “buy” rating and set a $16.00 price objective on the stock in a research note on Friday, February 13th. Wall Street Zen upgraded Adlai Nortye to a “hold” rating in a research note on Saturday, March 7th. Leerink Partners initiated coverage on Adlai Nortye in a research note on Friday, March 20th. They issued an “outperform” rating and a $23.00 price objective on the stock. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Adlai Nortye in a research note on Wednesday, January 21st. Two equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $19.50.

Adlai Nortye Company Profile

Adlai Nortye Inc (NASDAQ: ANL) is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.

Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.

The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.